Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-12-29
1977-12-06
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260465B, 260465D, 260518A, 260518R, 424287, 424289, 424295, 424309, 424316, 424317, 560 21, 560 36, A61K 31275
Patent
active
040617912
ABSTRACT:
A method of treating mammals for allergy and anaphylactic reactions of a reagin or non-reagin mediated nature which comprises administering prophylactically to said mammal an anti-allergy or anaphylactic reaction effective amount of a compound of the formula ##STR1## Novel compounds and compositions are also claimed.
REFERENCES:
patent: 3852324 (1974-12-01), Wright
patent: 3966965 (1976-06-01), Sellstedt et al.
Ciba, Chemical Abstracts 72:12413m, (1970).
Chemical Abstracts 60:2860e, (1963).
Hall Charles M.
Wright John B.
Barancik Martin B.
Schenkman Leonard
The Upjohn Company
LandOfFree
Anti-allergic oxanilate compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-allergic oxanilate compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-allergic oxanilate compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1551393